Big-Pharma Novartis to Charge $475,000 for $20,000 Cancer Cure Funded by Taxpayers and Charity

Posted: August 31, 2017 in Uncategorized

 

cure-for-leukemia-400x267

While Americans squabble over irrelevant political diversions, a revolutionary breakthrough in human healthcare has yielded its first FDA approval – a therapy that literally cures otherwise incurable leukemia.

It is the first of many therapies that re-engineer human cells in living patients to reprogram more resilient immune systems and even repair damaged or aging organs.

What would seem like headline news has instead squeaked through as a whimper – not because it is insignificant – but because of how this monumental breakthrough has been hijacked by special interests and how these interests plan on making Americans pay twice for its development behind a smokescreen of public ignorance.

Thanks to a media focused more on dividing and distracting Americans regarding irrelevant political charades, due diligence in researching the story was either sidestepped intentionally, or a result of unprofessional and incompetent journalism.

Taxpayers and Charity Paid First

For the past 20 years, American taxpayers through the National Institutes of Health (NIH) and the Leukemia & Lymphoma Society (LLS) helped fund a revolutionary cancer treatment that sidesteps devastating and ineffective chemotherapy and instead, re-engineers a patient’s own immune system to find and destroy tumors.

Source: Curing Incurable Leukemia

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s